D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 60 600 KRW Market Closed
Market Cap: 544.1B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note

Dong-A ST Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dong-A ST Co Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
D
Dong-A ST Co Ltd
KRX:170900
Capital Expenditures
-â‚©30.2B
CAGR 3-Years
23%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
Yuhan Corp
KRX:000100
Capital Expenditures
-â‚©153.3B
CAGR 3-Years
-14%
CAGR 5-Years
-26%
CAGR 10-Years
-15%
SK Biopharmaceuticals Co Ltd
KRX:326030
Capital Expenditures
-â‚©3.2B
CAGR 3-Years
39%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Capital Expenditures
-â‚©8.4B
CAGR 3-Years
-58%
CAGR 5-Years
-34%
CAGR 10-Years
-18%
Hanmi Pharm Co Ltd
KRX:128940
Capital Expenditures
-â‚©56.8B
CAGR 3-Years
-12%
CAGR 5-Years
23%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Capital Expenditures
-â‚©31.6B
CAGR 3-Years
-22%
CAGR 5-Years
-27%
CAGR 10-Years
-13%
No Stocks Found

Dong-A ST Co Ltd
Glance View

Market Cap
521.1B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
97 022.08 KRW
Undervaluation 38%
Intrinsic Value
Price
D

See Also

What is Dong-A ST Co Ltd's Capital Expenditures?
Capital Expenditures
-30.2B KRW

Based on the financial report for Sep 30, 2024, Dong-A ST Co Ltd's Capital Expenditures amounts to -30.2B KRW.

What is Dong-A ST Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-1%

Over the last year, the Capital Expenditures growth was 35%. The average annual Capital Expenditures growth rates for Dong-A ST Co Ltd have been 23% over the past three years , -11% over the past five years , and -1% over the past ten years .

Back to Top